NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Brink's Bets Big on ATMs: $6.6 Billion Deal to Acquire NCR Atleos

Brink's Company is set to buy NCR Atleos for $6.6 billion in cash and stock, merging two giants in financial tech to enhance ATM services and cash solutions for banks and retailers worldwide.

Brink's Bets Big on ATMs: $6.6 Billion Deal to Acquire NCR Atleos
Credit: NCR Atleos
Already have an account? Sign in.
02/27/2026 · 6:05 AM
NATL
/ Read more

Feed↓

Maven Goes Official: Palantir’s AI Now Permanent Part of U.S. Military
Featured/ 03/23/2026 · 9:55 AM

Maven Goes Official: Palantir’s AI Now Permanent Part of U.S. Military

Deputy SecDef Steve Feinberg orders Palantir's Maven AI system as a program of record, securing long-term funding and integration across U.S. forces by September 2026.

/ Subscriber only
Wolfe Research Turns Bullish on Celldex, Upgrading to Outperform and Citing Stronger 2026 Catalysts
03/23/2026 · 9:24 AM

Wolfe Research Turns Bullish on Celldex, Upgrading to Outperform and Citing Stronger 2026 Catalysts

Wolfe Research upgrades Celldex Therapeutics to Outperform from Peer Perform, citing stronger 2026 catalysts and depressed valuation for rebound potential.

/ Subscriber only
Pfizer and Valneva Lyme Vaccine Shows Over 70% Efficacy in Phase 3 Trial — But Misses Main Goal
03/23/2026 · 9:11 AM

Pfizer and Valneva Lyme Vaccine Shows Over 70% Efficacy in Phase 3 Trial — But Misses Main Goal

Pfizer and Valneva reported their Lyme disease vaccine demonstrated 73.2% efficacy in the Phase 3 VALOR trial. While it missed the primary statistical target due to fewer cases, strong results support upcoming regulatory submissions.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe